OQS
ESPR

Occudo Quantitative Strategies’s Esperion Therapeutics ESPR Stock Holding History

Occudo Quantitative Strategies’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-66,652
Closed -$447K – 1088
2022
Q3 		$447K Buy
66,652
+14,823
+29% +$102K 0.03% 702
2022
Q2 		$330K Sell
51,829
-65,586
-56% -$372K 0.03% 762
2022
Q1 		$545K Buy
117,415
+66,343
+130% +$285K 0.05% 614
2021
Q4 		$255K Buy
+51,072
New +$409K 0.02% 819
2021
Q3 		– Sell
-10,583
Closed -$224K – 1046
2021
Q2 		$224K Buy
+10,583
New +$255K 0.03% 701
2021
Q1 		– Sell
-14,520
Closed -$378K – 803
2020
Q4 		$378K Buy
+14,520
New +$435K 0.12% 342

Other funds holding ESPR

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return